Stay updated on INTRUST: Urelumab/Nivolumab Combo Clinical Trial

Sign up to get notified when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T23:54:50.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T05:46:18.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the full study record with a minimal message. As a result, core trial details and history sections are no longer visible, blocking access to the study information.
    Difference
    20%
    Check dated 2026-09-21T23:53:51.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.6, replacing the earlier v3.6.5 revision, signaling a minor update to the document version.
    Difference
    0.0%
    Check dated 2026-08-31T18:37:01.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.6.5 has been added to the page, replacing the previous v3.6.4, indicating a new page revision without visible data changes.
    Difference
    0.0%
    Check dated 2026-08-10T12:40:45.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page version was updated to v3.6.4, signaling a new release of the page's underlying framework. This update does not modify the study details or other user-facing information.
    Difference
    0.0%
    Check dated 2026-07-27T05:53:17.000Z thumbnail image

Stay in the know with updates to INTRUST: Urelumab/Nivolumab Combo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.